Evaluation of rapamycin-induced cell death

Lorenzo Galluzzi, Eugenia Morselli, Oliver Kepp, Ilio Vitale, Aména Ben Younes, Maria Chiara Maiuri, Guido Kroemer

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Mammalian target of rapamycin (mTOR) is an evolutionarily conserved kinase that integrates signals from nutrients and growth factors for the coordinate regulation of many cellular processes, including proliferation and cell death. Constitutive mTOR signaling characterizes multiple human malignancies, and pharmacological inhibitors of mTOR such as the immunosuppressant rapamycin and some of its nonimmunosuppressive derivatives not only have been ascribed with promising anticancer properties in vitro and in vivo but are also being extensively evaluated in clinical trials. mTOR inhibition rapidly leads to the activation of autophagy, which most often exerts prosurvival effects, although in some cases it accompanies cell death. Thus, depending on the specific experimental setting (cell type, concentration, stimulation time, and presence of concurrent stimuli), rapamycin can activate/favor a wide spectrum of cellular responses/phenotypes, ranging from adaptation to stress and survival to cell death. The (at least partial) overlap among the biochemical and morphological responses triggered by rapamycin considerably complicates the study of cell death-associated variables. Moreover, rapamycin presumably triggers acute cell death mainly via off-target mechanisms. Here, we describe a set of assays that can be employed for the routine quantification of rapamycin-induced cell death in vitro, as well as a set of guidelines that should be applied for their correct interpretation.

Original languageEnglish
Title of host publicationMethods in Molecular Biology
Pages125-169
Number of pages45
Volume821
DOIs
Publication statusPublished - 2012

Publication series

NameMethods in Molecular Biology
Volume821
ISSN (Print)10643745

Fingerprint

Sirolimus
Cell Death
Autophagy
Immunosuppressive Agents
Intercellular Signaling Peptides and Proteins
Phosphotransferases
Clinical Trials
Pharmacology
Guidelines
Phenotype
Food
Survival

Keywords

  • Apoptosis
  • Autophagosomes
  • Clonogenic assays
  • Immunoblotting
  • LC3
  • Mitochondrial membrane permeabilization
  • Phosphatidylserine exposure

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Cite this

Galluzzi, L., Morselli, E., Kepp, O., Vitale, I., Younes, A. B., Maiuri, M. C., & Kroemer, G. (2012). Evaluation of rapamycin-induced cell death. In Methods in Molecular Biology (Vol. 821, pp. 125-169). (Methods in Molecular Biology; Vol. 821). https://doi.org/10.1007/978-1-61779-430-8_9

Evaluation of rapamycin-induced cell death. / Galluzzi, Lorenzo; Morselli, Eugenia; Kepp, Oliver; Vitale, Ilio; Younes, Aména Ben; Maiuri, Maria Chiara; Kroemer, Guido.

Methods in Molecular Biology. Vol. 821 2012. p. 125-169 (Methods in Molecular Biology; Vol. 821).

Research output: Chapter in Book/Report/Conference proceedingChapter

Galluzzi, L, Morselli, E, Kepp, O, Vitale, I, Younes, AB, Maiuri, MC & Kroemer, G 2012, Evaluation of rapamycin-induced cell death. in Methods in Molecular Biology. vol. 821, Methods in Molecular Biology, vol. 821, pp. 125-169. https://doi.org/10.1007/978-1-61779-430-8_9
Galluzzi L, Morselli E, Kepp O, Vitale I, Younes AB, Maiuri MC et al. Evaluation of rapamycin-induced cell death. In Methods in Molecular Biology. Vol. 821. 2012. p. 125-169. (Methods in Molecular Biology). https://doi.org/10.1007/978-1-61779-430-8_9
Galluzzi, Lorenzo ; Morselli, Eugenia ; Kepp, Oliver ; Vitale, Ilio ; Younes, Aména Ben ; Maiuri, Maria Chiara ; Kroemer, Guido. / Evaluation of rapamycin-induced cell death. Methods in Molecular Biology. Vol. 821 2012. pp. 125-169 (Methods in Molecular Biology).
@inbook{469bea82bd2342eda4cc65de4b79b191,
title = "Evaluation of rapamycin-induced cell death",
abstract = "Mammalian target of rapamycin (mTOR) is an evolutionarily conserved kinase that integrates signals from nutrients and growth factors for the coordinate regulation of many cellular processes, including proliferation and cell death. Constitutive mTOR signaling characterizes multiple human malignancies, and pharmacological inhibitors of mTOR such as the immunosuppressant rapamycin and some of its nonimmunosuppressive derivatives not only have been ascribed with promising anticancer properties in vitro and in vivo but are also being extensively evaluated in clinical trials. mTOR inhibition rapidly leads to the activation of autophagy, which most often exerts prosurvival effects, although in some cases it accompanies cell death. Thus, depending on the specific experimental setting (cell type, concentration, stimulation time, and presence of concurrent stimuli), rapamycin can activate/favor a wide spectrum of cellular responses/phenotypes, ranging from adaptation to stress and survival to cell death. The (at least partial) overlap among the biochemical and morphological responses triggered by rapamycin considerably complicates the study of cell death-associated variables. Moreover, rapamycin presumably triggers acute cell death mainly via off-target mechanisms. Here, we describe a set of assays that can be employed for the routine quantification of rapamycin-induced cell death in vitro, as well as a set of guidelines that should be applied for their correct interpretation.",
keywords = "Apoptosis, Autophagosomes, Clonogenic assays, Immunoblotting, LC3, Mitochondrial membrane permeabilization, Phosphatidylserine exposure",
author = "Lorenzo Galluzzi and Eugenia Morselli and Oliver Kepp and Ilio Vitale and Younes, {Am{\'e}na Ben} and Maiuri, {Maria Chiara} and Guido Kroemer",
year = "2012",
doi = "10.1007/978-1-61779-430-8_9",
language = "English",
isbn = "9781617794292",
volume = "821",
series = "Methods in Molecular Biology",
pages = "125--169",
booktitle = "Methods in Molecular Biology",

}

TY - CHAP

T1 - Evaluation of rapamycin-induced cell death

AU - Galluzzi, Lorenzo

AU - Morselli, Eugenia

AU - Kepp, Oliver

AU - Vitale, Ilio

AU - Younes, Aména Ben

AU - Maiuri, Maria Chiara

AU - Kroemer, Guido

PY - 2012

Y1 - 2012

N2 - Mammalian target of rapamycin (mTOR) is an evolutionarily conserved kinase that integrates signals from nutrients and growth factors for the coordinate regulation of many cellular processes, including proliferation and cell death. Constitutive mTOR signaling characterizes multiple human malignancies, and pharmacological inhibitors of mTOR such as the immunosuppressant rapamycin and some of its nonimmunosuppressive derivatives not only have been ascribed with promising anticancer properties in vitro and in vivo but are also being extensively evaluated in clinical trials. mTOR inhibition rapidly leads to the activation of autophagy, which most often exerts prosurvival effects, although in some cases it accompanies cell death. Thus, depending on the specific experimental setting (cell type, concentration, stimulation time, and presence of concurrent stimuli), rapamycin can activate/favor a wide spectrum of cellular responses/phenotypes, ranging from adaptation to stress and survival to cell death. The (at least partial) overlap among the biochemical and morphological responses triggered by rapamycin considerably complicates the study of cell death-associated variables. Moreover, rapamycin presumably triggers acute cell death mainly via off-target mechanisms. Here, we describe a set of assays that can be employed for the routine quantification of rapamycin-induced cell death in vitro, as well as a set of guidelines that should be applied for their correct interpretation.

AB - Mammalian target of rapamycin (mTOR) is an evolutionarily conserved kinase that integrates signals from nutrients and growth factors for the coordinate regulation of many cellular processes, including proliferation and cell death. Constitutive mTOR signaling characterizes multiple human malignancies, and pharmacological inhibitors of mTOR such as the immunosuppressant rapamycin and some of its nonimmunosuppressive derivatives not only have been ascribed with promising anticancer properties in vitro and in vivo but are also being extensively evaluated in clinical trials. mTOR inhibition rapidly leads to the activation of autophagy, which most often exerts prosurvival effects, although in some cases it accompanies cell death. Thus, depending on the specific experimental setting (cell type, concentration, stimulation time, and presence of concurrent stimuli), rapamycin can activate/favor a wide spectrum of cellular responses/phenotypes, ranging from adaptation to stress and survival to cell death. The (at least partial) overlap among the biochemical and morphological responses triggered by rapamycin considerably complicates the study of cell death-associated variables. Moreover, rapamycin presumably triggers acute cell death mainly via off-target mechanisms. Here, we describe a set of assays that can be employed for the routine quantification of rapamycin-induced cell death in vitro, as well as a set of guidelines that should be applied for their correct interpretation.

KW - Apoptosis

KW - Autophagosomes

KW - Clonogenic assays

KW - Immunoblotting

KW - LC3

KW - Mitochondrial membrane permeabilization

KW - Phosphatidylserine exposure

UR - http://www.scopus.com/inward/record.url?scp=84555178349&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84555178349&partnerID=8YFLogxK

U2 - 10.1007/978-1-61779-430-8_9

DO - 10.1007/978-1-61779-430-8_9

M3 - Chapter

C2 - 22125064

AN - SCOPUS:84555178349

SN - 9781617794292

VL - 821

T3 - Methods in Molecular Biology

SP - 125

EP - 169

BT - Methods in Molecular Biology

ER -